Cargando…
Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects
The success of hematopoietic stem cell transplantation is determined by multiple factors. Additional complexity is conferred by covariables showing time-dependent effects. We evaluated the effect of predictors on competing-risk outcomes after hematopoietic stem cell transplantation in a time-depende...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119156/ https://www.ncbi.nlm.nih.gov/pubmed/29880610 http://dx.doi.org/10.3324/haematol.2017.183012 |
_version_ | 1783352032387661824 |
---|---|
author | Fuerst, Daniel Frank, Sandra Mueller, Carlheinz Beelen, Dietrich W Schetelig, Johannes Niederwieser, Dietger Finke, Jürgen Bunjes, Donald Kröger, Nicolaus Neuchel, Christine Tsamadou, Chrysanthi Schrezenmeier, Hubert Beyersmann, Jan Mytilineos, Joannis |
author_facet | Fuerst, Daniel Frank, Sandra Mueller, Carlheinz Beelen, Dietrich W Schetelig, Johannes Niederwieser, Dietger Finke, Jürgen Bunjes, Donald Kröger, Nicolaus Neuchel, Christine Tsamadou, Chrysanthi Schrezenmeier, Hubert Beyersmann, Jan Mytilineos, Joannis |
author_sort | Fuerst, Daniel |
collection | PubMed |
description | The success of hematopoietic stem cell transplantation is determined by multiple factors. Additional complexity is conferred by covariables showing time-dependent effects. We evaluated the effect of predictors on competing-risk outcomes after hematopoietic stem cell transplantation in a time-dependent manner. We analyzed 14951 outcomes of adult patients with hematologic malignancies who underwent a first allogeneic transplant. We extended the combined endpoints of disease-free and overall survival to competing-risk settings: disease-free survival was split into relapse and non-relapse mortality. Overall survival was divided into transplant-related mortality, death from other causes and death from unknown causes. For time-dependent effects we computed estimators before and after a covariable-specific cut-point. Patients treated with reduced intensity conditioning had a constantly higher risk of relapse compared to patients treated with myeloablative conditioning. For non-relapse mortality, patients treated with reduced intensity conditioning had a reduced mortality risk but this effect was only seen in the first 4 months after transplantation (hazard ratio: 0.76, P<0.001) and not afterwards. Graft source exhibited a time-dependent effect on both transplant-related mortality (in first year: hazard ratio 0.70, P<0.001; after first year: hazard ratio 1.47, P=0.002) and non-relapse mortality (in first 8 months: hazard ratio 0.75, P<0.001; after first 8 months: hazard ratio 1.38, P<0.001). Patients with a poor Karnofsky performance score (<80) had a considerably higher risk of all endpoints in the first 4 months. The competing-risk analysis for overall survival and disease-free survival allows resolution of effects with different vectors early and later after stem cell transplantation, as shown for graft source. This information may be useful in risk assessment of treatment choices and for counseling patients on an individual basis. |
format | Online Article Text |
id | pubmed-6119156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Ferrata Storti Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-61191562018-09-10 Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects Fuerst, Daniel Frank, Sandra Mueller, Carlheinz Beelen, Dietrich W Schetelig, Johannes Niederwieser, Dietger Finke, Jürgen Bunjes, Donald Kröger, Nicolaus Neuchel, Christine Tsamadou, Chrysanthi Schrezenmeier, Hubert Beyersmann, Jan Mytilineos, Joannis Haematologica Article The success of hematopoietic stem cell transplantation is determined by multiple factors. Additional complexity is conferred by covariables showing time-dependent effects. We evaluated the effect of predictors on competing-risk outcomes after hematopoietic stem cell transplantation in a time-dependent manner. We analyzed 14951 outcomes of adult patients with hematologic malignancies who underwent a first allogeneic transplant. We extended the combined endpoints of disease-free and overall survival to competing-risk settings: disease-free survival was split into relapse and non-relapse mortality. Overall survival was divided into transplant-related mortality, death from other causes and death from unknown causes. For time-dependent effects we computed estimators before and after a covariable-specific cut-point. Patients treated with reduced intensity conditioning had a constantly higher risk of relapse compared to patients treated with myeloablative conditioning. For non-relapse mortality, patients treated with reduced intensity conditioning had a reduced mortality risk but this effect was only seen in the first 4 months after transplantation (hazard ratio: 0.76, P<0.001) and not afterwards. Graft source exhibited a time-dependent effect on both transplant-related mortality (in first year: hazard ratio 0.70, P<0.001; after first year: hazard ratio 1.47, P=0.002) and non-relapse mortality (in first 8 months: hazard ratio 0.75, P<0.001; after first 8 months: hazard ratio 1.38, P<0.001). Patients with a poor Karnofsky performance score (<80) had a considerably higher risk of all endpoints in the first 4 months. The competing-risk analysis for overall survival and disease-free survival allows resolution of effects with different vectors early and later after stem cell transplantation, as shown for graft source. This information may be useful in risk assessment of treatment choices and for counseling patients on an individual basis. Ferrata Storti Foundation 2018-09 /pmc/articles/PMC6119156/ /pubmed/29880610 http://dx.doi.org/10.3324/haematol.2017.183012 Text en Copyright© 2018 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher. |
spellingShingle | Article Fuerst, Daniel Frank, Sandra Mueller, Carlheinz Beelen, Dietrich W Schetelig, Johannes Niederwieser, Dietger Finke, Jürgen Bunjes, Donald Kröger, Nicolaus Neuchel, Christine Tsamadou, Chrysanthi Schrezenmeier, Hubert Beyersmann, Jan Mytilineos, Joannis Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
title | Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
title_full | Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
title_fullStr | Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
title_full_unstemmed | Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
title_short | Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
title_sort | competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119156/ https://www.ncbi.nlm.nih.gov/pubmed/29880610 http://dx.doi.org/10.3324/haematol.2017.183012 |
work_keys_str_mv | AT fuerstdaniel competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT franksandra competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT muellercarlheinz competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT beelendietrichw competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT scheteligjohannes competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT niederwieserdietger competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT finkejurgen competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT bunjesdonald competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT krogernicolaus competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT neuchelchristine competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT tsamadouchrysanthi competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT schrezenmeierhubert competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT beyersmannjan competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects AT mytilineosjoannis competingriskoutcomesafterhematopoieticstemcelltransplantationfromtheperspectiveoftimedependenteffects |